+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Medical Radioactive Iodine I-131 Market - Global Forecast 2026-2032- Product Image
Medical Radioactive Iodine I-131 Market - Global Forecast 2026-2032- Product Image
Sale

Medical Radioactive Iodine I-131 Market - Global Forecast 2026-2032

  • Report

  • 186 Pages
  • September 2026
  • Region: Global
  • 360iResearch™
  • ID: 6140156
UP TO OFF until Jan 01st 2027
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.
The Medical Radioactive Iodine I-131 Market is projected to reach USD 520.84 Million in 2026. It is expected to continue growing at a CAGR of 11.82%, reaching USD 1.02 Billion by 2032.

Medical Radioactive Iodine I-131: Executive Summary

Medical radioactive iodine I-131 is a clinically established radionuclide used primarily in the diagnosis and treatment of thyroid disorders, including differentiated thyroid cancer and hyperthyroidism. Its value chain depends on reactor or accelerator production, radiochemical processing, regulatory authorization, specialized transport, hospital nuclear-medicine infrastructure, and trained clinical personnel. Because I-131 emits both beta and gamma radiation, safe use requires controlled handling, patient-specific dosimetry, radiation protection, and compliant radioactive-waste management.

Supply Resilience and Care Pathways Are Reshaping I-131 Use

The landscape is being transformed by tighter radiation-safety requirements, aging reactor infrastructure, transport constraints, and the need for dependable isotope availability. Healthcare systems are also emphasizing outpatient treatment where clinically appropriate, standardized isolation guidance, digital scheduling, and coordinated endocrinology, oncology, nuclear-medicine, and medical-physics workflows. These changes favor resilient procurement, validated logistics, contingency planning, and consistent clinical protocols rather than reliance on a single production or distribution route.

Artificial Intelligence Strengthens Selection, Scheduling, and Safety

Artificial intelligence can support I-131 care by improving thyroid imaging interpretation, identifying patients who may benefit from radioiodine therapy, assisting dose-planning decisions, and detecting inconsistencies in clinical records. Predictive tools may also help coordinate appointments, isotope delivery, room availability, and follow-up monitoring. However, AI should remain subject to clinician oversight, transparent validation, cybersecurity controls, privacy safeguards, and regulatory review. Its most dependable contribution is decision support integrated with established nuclear-medicine and radiation-protection practices.

Regional Insights: Regulation and Infrastructure Shape Access

North America generally benefits from advanced nuclear-medicine infrastructure, specialist capacity, and mature regulatory systems, while Canada and the United States continue to prioritize reliable isotope logistics and safe outpatient pathways. Europe combines strong clinical expertise with coordinated safety standards, although cross-border transport and differing national procedures require careful planning. Asia-Pacific presents substantial clinical capability alongside uneven access between advanced metropolitan centers and less-resourced areas. Latin America is shaped by concentrated specialist services, import dependence in some settings, and variable infrastructure. The Middle East is expanding specialized healthcare capacity, with access influenced by national investment and cross-border procurement. Africa remains highly heterogeneous, with established services in selected countries and persistent challenges involving equipment, trained staff, isotope logistics, and continuity of care.

Group Insights: Economic and Security Blocs Influence Coordination

ASEAN members face varied nuclear-medicine capacity and may benefit from stronger regional training, referral networks, and coordinated logistics. BRICS countries span major producers, large patient populations, and differing regulatory systems, making interoperability and supply resilience important priorities. The European Union benefits from shared regulatory dialogue while retaining national differences in reimbursement and clinical implementation. G7 countries typically have advanced specialist services but must address aging infrastructure, workforce succession, and continuity during isotope disruptions. GCC states are investing in sophisticated healthcare facilities and may rely on centralized procurement and international expertise. NATO members are relevant to resilience planning because critical infrastructure protection, emergency preparedness, and secure transport can affect medical-isotope continuity.

Country Insights: National Capacity Determines Clinical Continuity

Australia combines specialist nuclear-medicine services with long-distance logistics and geographic concentration. Brazil and Mexico must balance large and diverse patient populations with uneven regional access. Canada and the United States have mature clinical systems but require sustained infrastructure, workforce, and supply-chain resilience. China and India are expanding nuclear-medicine capabilities across broad healthcare geographies, with continued emphasis on quality consistency and specialist training. Japan, South Korea, and Russia maintain substantial technical expertise, while regulatory and logistical continuity remain important. France, Germany, Italy, Spain, and the United Kingdom benefit from established thyroid-care pathways and specialist networks, yet face pressure to modernize facilities and maintain staffing. Across all countries, timely access depends on authorized production, compliant transport, calibrated equipment, trained personnel, and equitable referral pathways.

Action Priorities for Leaders: Secure Supply, Standardize Care, Strengthen Workforce

Industry leaders should diversify qualified isotope sources, establish disruption playbooks, and monitor transport and regulatory dependencies across the full chain. Hospitals should standardize patient selection, informed consent, dosimetry, discharge criteria, contamination controls, and follow-up documentation while adapting protocols to local rules. Investment in medical-physics and nuclear-medicine training is essential, particularly outside major urban centers. Leaders should deploy AI only through clinically validated workflows, maintain human accountability, and audit performance for bias and safety. Partnerships among producers, regulators, hospitals, universities, and referral networks can improve continuity, evidence generation, and equitable access.

Research Methodology: Evidence-Based Assessment of the I-131 Care Ecosystem

This executive summary uses a structured review of the medical radioactive iodine I-131 ecosystem, examining clinical applications, production and processing requirements, regulation, transport, radiation protection, healthcare infrastructure, workforce capability, and digital transformation. Regional, group, and country perspectives are synthesized from publicly documented institutional, governmental, regulatory, and clinical evidence. Interpretations are limited to verifiable structural and operational insights; no market estimates, market sizing, market shares, forecasts, or company-specific claims are included.

Conclusion: Resilience and Clinical Governance Will Define Progress

Medical radioactive iodine I-131 remains an important tool in thyroid disease management, but dependable patient access relies on more than isotope production alone. Resilient supply chains, rigorous radiation safety, coordinated clinical pathways, qualified personnel, modern infrastructure, and responsible use of AI jointly determine outcomes. Leaders that connect these capabilities across national and regional systems will be better positioned to support safe, timely, and equitable I-131 care.

This product will be delivered within 1-3 business days.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Definition
1.3. Market Segmentation & Coverage
1.4. Years Considered for the Study
1.5. Currency Considered for the Study
1.6. Language Considered for the Study
1.7. Key Stakeholders
2. Research Methodology
2.1. Introduction
2.2. Research Design
2.2.1. Primary Research
2.2.2. Secondary Research
2.3. Research Framework
2.3.1. Qualitative Analysis
2.3.2. Quantitative Analysis
2.4. Market Size Estimation
2.4.1. Top-Down Approach
2.4.2. Bottom-Up Approach
2.5. Data Triangulation
2.6. Research Outcomes
2.7. Research Assumptions
2.8. Research Limitations
3. Executive Summary
3.1. Introduction
3.2. CXO Perspective
3.3. New Revenue Opportunities
3.4. Next-Generation Business Models
3.5. Industry Roadmap
4. Market Overview
4.1. Introduction
4.2. Industry Ecosystem & Value Chain Analysis
4.2.1. Supply-Side Analysis
4.2.2. Demand-Side Analysis
4.2.3. Stakeholder Analysis
4.3. Market Dynamics
4.3.1. Key Drivers
4.3.2. Key Restraints
4.3.3. Key Opportunities
4.3.4. Key Challenges
4.4. Porter’s Five Forces Analysis
4.5. PESTLE Analysis
4.6. Market Outlook
4.6.1. Near-Term Market Outlook (0-2 Years)
4.6.2. Medium-Term Market Outlook (3-5 Years)
4.6.3. Long-Term Market Outlook (5-10 Years)
4.7. Go-to-Market Strategy
5. Market Insights
5.1. Consumer Insights & End-User Perspective
5.2. Consumer Experience Benchmarking
5.3. Opportunity Mapping
5.4. Distribution Channel Analysis
5.5. Pricing Trend Analysis
5.6. Regulatory Compliance & Standards Framework
5.7. ESG & Sustainability Analysis
5.8. Disruption & Risk Scenarios
5.9. Return on Investment & Cost-Benefit Analysis
6. Cumulative Impact of Artificial Intelligence 2026
7. Medical Radioactive Iodine I-131 Market, by Product
7.1. Introduction
7.2. Capsule
7.3. Solution
8. Medical Radioactive Iodine I-131 Market, by Application
8.1. Introduction
8.2. Diagnostic
8.3. Therapeutic
8.3.1. Hyperthyroidism
8.3.2. Thyroid Cancer
9. Medical Radioactive Iodine I-131 Market, by End User
9.1. Introduction
9.2. Clinics
9.2.1. Diagnostic Lab
9.2.2. Outpatient Center
9.3. Hospitals
9.3.1. Specialty Cancer Center
9.3.2. Tertiary Care Hospital
9.4. Research Institutes
9.4.1. Academic Research Center
9.4.2. Contract Research Organization
10. Medical Radioactive Iodine I-131 Market, by Distribution Channel
10.1. Introduction
10.2. Online Pharmacy
10.3. Hospital Pharmacy
10.4. Retail Pharmacy
11. Medical Radioactive Iodine I-131 Market, by Region
11.1. Introduction
11.2. Asia-Pacific
11.3. North America
11.4. Latin America
11.5. Europe
11.6. Middle East
11.7. Africa
12. Medical Radioactive Iodine I-131 Market, by Group
12.1. Introduction
12.2. ASEAN
12.3. GCC
12.4. European Union
12.5. BRICS
12.6. G7
12.7. NATO
13. Medical Radioactive Iodine I-131 Market, by Country
13.1. Introduction
13.2. United States
13.3. Canada
13.4. Mexico
13.5. Brazil
13.6. United Kingdom
13.7. Germany
13.8. France
13.9. Russia
13.10. Italy
13.11. Spain
13.12. China
13.13. India
13.14. Japan
13.15. Australia
13.16. South Korea
14. Competitive Landscape
14.1. Market Share Analysis, 2025
14.2. Market Concentration Analysis, 2025
14.2.1. Concentration Ratio (CR)
14.2.2. Herfindahl Hirschman Index (HHI)
14.3. Recent Developments & Impact Analysis, 2025
14.4. Product Portfolio Analysis, 2025
14.5. Benchmarking Analysis, 2025
15. Company Profiles
15.1. Advanced Biomedicals
15.2. Bayer AG
15.3. Biodex Medical Systems
15.4. Bracco Imaging S.p.A.
15.5. CIS Bio International
15.6. Curium Pharma
15.7. Fujifilm Holdings Corporation
15.8. GE Healthcare
15.9. IBA Molecular
15.10. Isotope Products Laboratories
15.11. ITM Isotope Technologies Munich
15.12. Jubilant DraxImage Inc.
15.13. Lantheus Medical Imaging
15.14. Mallinckrodt Pharmaceuticals
15.15. Nordion Canada
15.16. Nordion Inc.
15.17. Nordion Ltd.
15.18. PerkinElmer, Inc.
15.19. Radiopharm Theranostics
15.20. SHINE Medical Technologies
15.21. Siemens Healthineers
15.22. Sumitomo Heavy Industries, Ltd.
16. Key Experts
LIST OF FIGURES
FIGURE 1. Global Medical Radioactive Iodine I-131 Market, Years Considered for the Study
FIGURE 2. Global Medical Radioactive Iodine I-131 Market, Research Design
FIGURE 3. Global Medical Radioactive Iodine I-131 Market, Research Framework
FIGURE 4. Global Medical Radioactive Iodine I-131 Market, Data Triangulation
FIGURE 5. Global Medical Radioactive Iodine I-131 Market Size, 2017-2032 (USD Million)
FIGURE 6. Global Medical Radioactive Iodine I-131 Market Size, by Product, 2025 vs 2032 (%)
FIGURE 7. Global Medical Radioactive Iodine I-131 Market Size, by Product, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 8. Global Medical Radioactive Iodine I-131 Market Size, by Application, 2025 vs 2032 (%)
FIGURE 9. Global Medical Radioactive Iodine I-131 Market Size, by Application, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 10. Global Medical Radioactive Iodine I-131 Market Size, by End User, 2025 vs 2032 (%)
FIGURE 11. Global Medical Radioactive Iodine I-131 Market Size, by End User, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 12. Global Medical Radioactive Iodine I-131 Market Size, by Distribution Channel, 2025 vs 2032 (%)
FIGURE 13. Global Medical Radioactive Iodine I-131 Market Size, by Distribution Channel, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 14. Global Medical Radioactive Iodine I-131 Market Size, by Region, 2025 vs 2032 (%)
FIGURE 15. Global Medical Radioactive Iodine I-131 Market Size, by Region, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 16. Global Medical Radioactive Iodine I-131 Market Size, by Group, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 17. Global Medical Radioactive Iodine I-131 Market Size, by Country, 2025 vs 2032 (%)
FIGURE 18. Global Medical Radioactive Iodine I-131 Market Size, by Country, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 19. Global Medical Radioactive Iodine I-131 Market Share, by Key Player, 2025
LIST OF TABLES
TABLE 1. Global Medical Radioactive Iodine I-131 Market Segmentation & Coverage
TABLE 2. Global Medical Radioactive Iodine I-131 Market Size, 2017-2032 (USD Million)
TABLE 3. Global Medical Radioactive Iodine I-131 Market Size, by Product, 2017-2032 (USD Million)
TABLE 4. Global Capsule Market Size, by Region, 2017-2032 (USD Million)
TABLE 5. Global Capsule Market Size, by Group, 2017-2032 (USD Million)
TABLE 6. Global Capsule Market Size, by Country, 2017-2032 (USD Million)
TABLE 7. Global Solution Market Size, by Region, 2017-2032 (USD Million)
TABLE 8. Global Solution Market Size, by Group, 2017-2032 (USD Million)
TABLE 9. Global Solution Market Size, by Country, 2017-2032 (USD Million)
TABLE 10. Global Medical Radioactive Iodine I-131 Market Size, by Application, 2017-2032 (USD Million)
TABLE 11. Global Diagnostic Market Size, by Region, 2017-2032 (USD Million)
TABLE 12. Global Diagnostic Market Size, by Group, 2017-2032 (USD Million)
TABLE 13. Global Diagnostic Market Size, by Country, 2017-2032 (USD Million)
TABLE 14. Global Therapeutic Market Size, by Region, 2017-2032 (USD Million)
TABLE 15. Global Therapeutic Market Size, by Group, 2017-2032 (USD Million)
TABLE 16. Global Therapeutic Market Size, by Country, 2017-2032 (USD Million)
TABLE 17. Global Hyperthyroidism Market Size, by Region, 2017-2032 (USD Million)
TABLE 18. Global Hyperthyroidism Market Size, by Group, 2017-2032 (USD Million)
TABLE 19. Global Hyperthyroidism Market Size, by Country, 2017-2032 (USD Million)
TABLE 20. Global Thyroid Cancer Market Size, by Region, 2017-2032 (USD Million)
TABLE 21. Global Thyroid Cancer Market Size, by Group, 2017-2032 (USD Million)
TABLE 22. Global Thyroid Cancer Market Size, by Country, 2017-2032 (USD Million)
TABLE 23. Global Medical Radioactive Iodine I-131 Market Size, by End User, 2017-2032 (USD Million)
TABLE 24. Global Clinics Market Size, by Region, 2017-2032 (USD Million)
TABLE 25. Global Clinics Market Size, by Group, 2017-2032 (USD Million)
TABLE 26. Global Clinics Market Size, by Country, 2017-2032 (USD Million)
TABLE 27. Global Diagnostic Lab Market Size, by Region, 2017-2032 (USD Million)
TABLE 28. Global Diagnostic Lab Market Size, by Group, 2017-2032 (USD Million)
TABLE 29. Global Diagnostic Lab Market Size, by Country, 2017-2032 (USD Million)
TABLE 30. Global Outpatient Center Market Size, by Region, 2017-2032 (USD Million)
TABLE 31. Global Outpatient Center Market Size, by Group, 2017-2032 (USD Million)
TABLE 32. Global Outpatient Center Market Size, by Country, 2017-2032 (USD Million)
TABLE 33. Global Hospitals Market Size, by Region, 2017-2032 (USD Million)
TABLE 34. Global Hospitals Market Size, by Group, 2017-2032 (USD Million)
TABLE 35. Global Hospitals Market Size, by Country, 2017-2032 (USD Million)
TABLE 36. Global Specialty Cancer Center Market Size, by Region, 2017-2032 (USD Million)
TABLE 37. Global Specialty Cancer Center Market Size, by Group, 2017-2032 (USD Million)
TABLE 38. Global Specialty Cancer Center Market Size, by Country, 2017-2032 (USD Million)
TABLE 39. Global Tertiary Care Hospital Market Size, by Region, 2017-2032 (USD Million)
TABLE 40. Global Tertiary Care Hospital Market Size, by Group, 2017-2032 (USD Million)
TABLE 41. Global Tertiary Care Hospital Market Size, by Country, 2017-2032 (USD Million)
TABLE 42. Global Research Institutes Market Size, by Region, 2017-2032 (USD Million)
TABLE 43. Global Research Institutes Market Size, by Group, 2017-2032 (USD Million)
TABLE 44. Global Research Institutes Market Size, by Country, 2017-2032 (USD Million)
TABLE 45. Global Academic Research Center Market Size, by Region, 2017-2032 (USD Million)
TABLE 46. Global Academic Research Center Market Size, by Group, 2017-2032 (USD Million)
TABLE 47. Global Academic Research Center Market Size, by Country, 2017-2032 (USD Million)
TABLE 48. Global Contract Research Organization Market Size, by Region, 2017-2032 (USD Million)
TABLE 49. Global Contract Research Organization Market Size, by Group, 2017-2032 (USD Million)
TABLE 50. Global Contract Research Organization Market Size, by Country, 2017-2032 (USD Million)
TABLE 51. Global Medical Radioactive Iodine I-131 Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 52. Global Online Pharmacy Market Size, by Region, 2017-2032 (USD Million)
TABLE 53. Global Online Pharmacy Market Size, by Group, 2017-2032 (USD Million)
TABLE 54. Global Online Pharmacy Market Size, by Country, 2017-2032 (USD Million)
TABLE 55. Global Hospital Pharmacy Market Size, by Region, 2017-2032 (USD Million)
TABLE 56. Global Hospital Pharmacy Market Size, by Group, 2017-2032 (USD Million)
TABLE 57. Global Hospital Pharmacy Market Size, by Country, 2017-2032 (USD Million)
TABLE 58. Global Retail Pharmacy Market Size, by Region, 2017-2032 (USD Million)
TABLE 59. Global Retail Pharmacy Market Size, by Group, 2017-2032 (USD Million)
TABLE 60. Global Retail Pharmacy Market Size, by Country, 2017-2032 (USD Million)
TABLE 61. Global Medical Radioactive Iodine I-131 Market Size, by Region, 2017-2032 (USD Million)
TABLE 62. Asia-Pacific Medical Radioactive Iodine I-131 Market Size, by Region, 2017-2032 (USD Million)
TABLE 63. Asia-Pacific Medical Radioactive Iodine I-131 Market Size, by Product, 2017-2032 (USD Million)
TABLE 64. Asia-Pacific Medical Radioactive Iodine I-131 Market Size, by Application, 2017-2032 (USD Million)
TABLE 65. Asia-Pacific Medical Radioactive Iodine I-131 Market Size, by Therapeutic, 2017-2032 (USD Million)
TABLE 66. Asia-Pacific Medical Radioactive Iodine I-131 Market Size, by End User, 2017-2032 (USD Million)
TABLE 67. Asia-Pacific Medical Radioactive Iodine I-131 Market Size, by Clinics, 2017-2032 (USD Million)
TABLE 68. Asia-Pacific Medical Radioactive Iodine I-131 Market Size, by Hospitals, 2017-2032 (USD Million)
TABLE 69. Asia-Pacific Medical Radioactive Iodine I-131 Market Size, by Research Institutes, 2017-2032 (USD Million)
TABLE 70. Asia-Pacific Medical Radioactive Iodine I-131 Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 71. North America Medical Radioactive Iodine I-131 Market Size, by Region, 2017-2032 (USD Million)
TABLE 72. North America Medical Radioactive Iodine I-131 Market Size, by Product, 2017-2032 (USD Million)
TABLE 73. North America Medical Radioactive Iodine I-131 Market Size, by Application, 2017-2032 (USD Million)
TABLE 74. North America Medical Radioactive Iodine I-131 Market Size, by Therapeutic, 2017-2032 (USD Million)
TABLE 75. North America Medical Radioactive Iodine I-131 Market Size, by End User, 2017-2032 (USD Million)
TABLE 76. North America Medical Radioactive Iodine I-131 Market Size, by Clinics, 2017-2032 (USD Million)
TABLE 77. North America Medical Radioactive Iodine I-131 Market Size, by Hospitals, 2017-2032 (USD Million)
TABLE 78. North America Medical Radioactive Iodine I-131 Market Size, by Research Institutes, 2017-2032 (USD Million)
TABLE 79. North America Medical Radioactive Iodine I-131 Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 80. Latin America Medical Radioactive Iodine I-131 Market Size, by Region, 2017-2032 (USD Million)
TABLE 81. Latin America Medical Radioactive Iodine I-131 Market Size, by Product, 2017-2032 (USD Million)
TABLE 82. Latin America Medical Radioactive Iodine I-131 Market Size, by Application, 2017-2032 (USD Million)
TABLE 83. Latin America Medical Radioactive Iodine I-131 Market Size, by Therapeutic, 2017-2032 (USD Million)
TABLE 84. Latin America Medical Radioactive Iodine I-131 Market Size, by End User, 2017-2032 (USD Million)
TABLE 85. Latin America Medical Radioactive Iodine I-131 Market Size, by Clinics, 2017-2032 (USD Million)
TABLE 86. Latin America Medical Radioactive Iodine I-131 Market Size, by Hospitals, 2017-2032 (USD Million)
TABLE 87. Latin America Medical Radioactive Iodine I-131 Market Size, by Research Institutes, 2017-2032 (USD Million)
TABLE 88. Latin America Medical Radioactive Iodine I-131 Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 89. Europe Medical Radioactive Iodine I-131 Market Size, by Region, 2017-2032 (USD Million)
TABLE 90. Europe Medical Radioactive Iodine I-131 Market Size, by Product, 2017-2032 (USD Million)
TABLE 91. Europe Medical Radioactive Iodine I-131 Market Size, by Application, 2017-2032 (USD Million)
TABLE 92. Europe Medical Radioactive Iodine I-131 Market Size, by Therapeutic, 2017-2032 (USD Million)
TABLE 93. Europe Medical Radioactive Iodine I-131 Market Size, by End User, 2017-2032 (USD Million)
TABLE 94. Europe Medical Radioactive Iodine I-131 Market Size, by Clinics, 2017-2032 (USD Million)
TABLE 95. Europe Medical Radioactive Iodine I-131 Market Size, by Hospitals, 2017-2032 (USD Million)
TABLE 96. Europe Medical Radioactive Iodine I-131 Market Size, by Research Institutes, 2017-2032 (USD Million)
TABLE 97. Europe Medical Radioactive Iodine I-131 Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 98. Middle East Medical Radioactive Iodine I-131 Market Size, by Region, 2017-2032 (USD Million)
TABLE 99. Middle East Medical Radioactive Iodine I-131 Market Size, by Product, 2017-2032 (USD Million)
TABLE 100. Middle East Medical Radioactive Iodine I-131 Market Size, by Application, 2017-2032 (USD Million)
TABLE 101. Middle East Medical Radioactive Iodine I-131 Market Size, by Therapeutic, 2017-2032 (USD Million)
TABLE 102. Middle East Medical Radioactive Iodine I-131 Market Size, by End User, 2017-2032 (USD Million)
TABLE 103. Middle East Medical Radioactive Iodine I-131 Market Size, by Clinics, 2017-2032 (USD Million)
TABLE 104. Middle East Medical Radioactive Iodine I-131 Market Size, by Hospitals, 2017-2032 (USD Million)
TABLE 105. Middle East Medical Radioactive Iodine I-131 Market Size, by Research Institutes, 2017-2032 (USD Million)
TABLE 106. Middle East Medical Radioactive Iodine I-131 Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 107. Africa Medical Radioactive Iodine I-131 Market Size, by Region, 2017-2032 (USD Million)
TABLE 108. Africa Medical Radioactive Iodine I-131 Market Size, by Product, 2017-2032 (USD Million)
TABLE 109. Africa Medical Radioactive Iodine I-131 Market Size, by Application, 2017-2032 (USD Million)
TABLE 110. Africa Medical Radioactive Iodine I-131 Market Size, by Therapeutic, 2017-2032 (USD Million)
TABLE 111. Africa Medical Radioactive Iodine I-131 Market Size, by End User, 2017-2032 (USD Million)
TABLE 112. Africa Medical Radioactive Iodine I-131 Market Size, by Clinics, 2017-2032 (USD Million)
TABLE 113. Africa Medical Radioactive Iodine I-131 Market Size, by Hospitals, 2017-2032 (USD Million)
TABLE 114. Africa Medical Radioactive Iodine I-131 Market Size, by Research Institutes, 2017-2032 (USD Million)
TABLE 115. Africa Medical Radioactive Iodine I-131 Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 116. Global Medical Radioactive Iodine I-131 Market Size, by Group, 2017-2032 (USD Million)
TABLE 117. ASEAN Medical Radioactive Iodine I-131 Market Size, by Group, 2017-2032 (USD Million)
TABLE 118. ASEAN Medical Radioactive Iodine I-131 Market Size, by Product, 2017-2032 (USD Million)
TABLE 119. ASEAN Medical Radioactive Iodine I-131 Market Size, by Application, 2017-2032 (USD Million)
TABLE 120. ASEAN Medical Radioactive Iodine I-131 Market Size, by Therapeutic, 2017-2032 (USD Million)
TABLE 121. ASEAN Medical Radioactive Iodine I-131 Market Size, by End User, 2017-2032 (USD Million)
TABLE 122. ASEAN Medical Radioactive Iodine I-131 Market Size, by Clinics, 2017-2032 (USD Million)
TABLE 123. ASEAN Medical Radioactive Iodine I-131 Market Size, by Hospitals, 2017-2032 (USD Million)
TABLE 124. ASEAN Medical Radioactive Iodine I-131 Market Size, by Research Institutes, 2017-2032 (USD Million)
TABLE 125. ASEAN Medical Radioactive Iodine I-131 Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 126. GCC Medical Radioactive Iodine I-131 Market Size, by Group, 2017-2032 (USD Million)
TABLE 127. GCC Medical Radioactive Iodine I-131 Market Size, by Product, 2017-2032 (USD Million)
TABLE 128. GCC Medical Radioactive Iodine I-131 Market Size, by Application, 2017-2032 (USD Million)
TABLE 129. GCC Medical Radioactive Iodine I-131 Market Size, by Therapeutic, 2017-2032 (USD Million)
TABLE 130. GCC Medical Radioactive Iodine I-131 Market Size, by End User, 2017-2032 (USD Million)
TABLE 131. GCC Medical Radioactive Iodine I-131 Market Size, by Clinics, 2017-2032 (USD Million)
TABLE 132. GCC Medical Radioactive Iodine I-131 Market Size, by Hospitals, 2017-2032 (USD Million)
TABLE 133. GCC Medical Radioactive Iodine I-131 Market Size, by Research Institutes, 2017-2032 (USD Million)
TABLE 134. GCC Medical Radioactive Iodine I-131 Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 135. European Union Medical Radioactive Iodine I-131 Market Size, by Group, 2017-2032 (USD Million)
TABLE 136. European Union Medical Radioactive Iodine I-131 Market Size, by Product, 2017-2032 (USD Million)
TABLE 137. European Union Medical Radioactive Iodine I-131 Market Size, by Application, 2017-2032 (USD Million)
TABLE 138. European Union Medical Radioactive Iodine I-131 Market Size, by Therapeutic, 2017-2032 (USD Million)
TABLE 139. European Union Medical Radioactive Iodine I-131 Market Size, by End User, 2017-2032 (USD Million)
TABLE 140. European Union Medical Radioactive Iodine I-131 Market Size, by Clinics, 2017-2032 (USD Million)
TABLE 141. European Union Medical Radioactive Iodine I-131 Market Size, by Hospitals, 2017-2032 (USD Million)
TABLE 142. European Union Medical Radioactive Iodine I-131 Market Size, by Research Institutes, 2017-2032 (USD Million)
TABLE 143. European Union Medical Radioactive Iodine I-131 Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 144. BRICS Medical Radioactive Iodine I-131 Market Size, by Group, 2017-2032 (USD Million)
TABLE 145. BRICS Medical Radioactive Iodine I-131 Market Size, by Product, 2017-2032 (USD Million)
TABLE 146. BRICS Medical Radioactive Iodine I-131 Market Size, by Application, 2017-2032 (USD Million)
TABLE 147. BRICS Medical Radioactive Iodine I-131 Market Size, by Therapeutic, 2017-2032 (USD Million)
TABLE 148. BRICS Medical Radioactive Iodine I-131 Market Size, by End User, 2017-2032 (USD Million)
TABLE 149. BRICS Medical Radioactive Iodine I-131 Market Size, by Clinics, 2017-2032 (USD Million)
TABLE 150. BRICS Medical Radioactive Iodine I-131 Market Size, by Hospitals, 2017-2032 (USD Million)
TABLE 151. BRICS Medical Radioactive Iodine I-131 Market Size, by Research Institutes, 2017-2032 (USD Million)
TABLE 152. BRICS Medical Radioactive Iodine I-131 Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 153. G7 Medical Radioactive Iodine I-131 Market Size, by Group, 2017-2032 (USD Million)
TABLE 154. G7 Medical Radioactive Iodine I-131 Market Size, by Product, 2017-2032 (USD Million)
TABLE 155. G7 Medical Radioactive Iodine I-131 Market Size, by Application, 2017-2032 (USD Million)
TABLE 156. G7 Medical Radioactive Iodine I-131 Market Size, by Therapeutic, 2017-2032 (USD Million)
TABLE 157. G7 Medical Radioactive Iodine I-131 Market Size, by End User, 2017-2032 (USD Million)
TABLE 158. G7 Medical Radioactive Iodine I-131 Market Size, by Clinics, 2017-2032 (USD Million)
TABLE 159. G7 Medical Radioactive Iodine I-131 Market Size, by Hospitals, 2017-2032 (USD Million)
TABLE 160. G7 Medical Radioactive Iodine I-131 Market Size, by Research Institutes, 2017-2032 (USD Million)
TABLE 161. G7 Medical Radioactive Iodine I-131 Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 162. NATO Medical Radioactive Iodine I-131 Market Size, by Group, 2017-2032 (USD Million)
TABLE 163. NATO Medical Radioactive Iodine I-131 Market Size, by Product, 2017-2032 (USD Million)
TABLE 164. NATO Medical Radioactive Iodine I-131 Market Size, by Application, 2017-2032 (USD Million)
TABLE 165. NATO Medical Radioactive Iodine I-131 Market Size, by Therapeutic, 2017-2032 (USD Million)
TABLE 166. NATO Medical Radioactive Iodine I-131 Market Size, by End User, 2017-2032 (USD Million)
TABLE 167. NATO Medical Radioactive Iodine I-131 Market Size, by Clinics, 2017-2032 (USD Million)
TABLE 168. NATO Medical Radioactive Iodine I-131 Market Size, by Hospitals, 2017-2032 (USD Million)
TABLE 169. NATO Medical Radioactive Iodine I-131 Market Size, by Research Institutes, 2017-2032 (USD Million)
TABLE 170. NATO Medical Radioactive Iodine I-131 Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 171. Global Medical Radioactive Iodine I-131 Market Size, by Country, 2017-2032 (USD Million)
TABLE 172. United States Medical Radioactive Iodine I-131 Market Size, 2017-2032 (USD Million)
TABLE 173. United States Medical Radioactive Iodine I-131 Market Size, by Product, 2017-2032 (USD Million)
TABLE 174. United States Medical Radioactive Iodine I-131 Market Size, by Application, 2017-2032 (USD Million)
TABLE 175. United States Medical Radioactive Iodine I-131 Market Size, by Therapeutic, 2017-2032 (USD Million)
TABLE 176. United States Medical Radioactive Iodine I-131 Market Size, by End User, 2017-2032 (USD Million)
TABLE 177. United States Medical Radioactive Iodine I-131 Market Size, by Clinics, 2017-2032 (USD Million)
TABLE 178. United States Medical Radioactive Iodine I-131 Market Size, by Hospitals, 2017-2032 (USD Million)
TABLE 179. United States Medical Radioactive Iodine I-131 Market Size, by Research Institutes, 2017-2032 (USD Million)
TABLE 180. United States Medical Radioactive Iodine I-131 Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 181. Canada Medical Radioactive Iodine I-131 Market Size, 2017-2032 (USD Million)
TABLE 182. Canada Medical Radioactive Iodine I-131 Market Size, by Product, 2017-2032 (USD Million)
TABLE 183. Canada Medical Radioactive Iodine I-131 Market Size, by Application, 2017-2032 (USD Million)
TABLE 184. Canada Medical Radioactive Iodine I-131 Market Size, by Therapeutic, 2017-2032 (USD Million)
TABLE 185. Canada Medical Radioactive Iodine I-131 Market Size, by End User, 2017-2032 (USD Million)
TABLE 186. Canada Medical Radioactive Iodine I-131 Market Size, by Clinics, 2017-2032 (USD Million)
TABLE 187. Canada Medical Radioactive Iodine I-131 Market Size, by Hospitals, 2017-2032 (USD Million)
TABLE 188. Canada Medical Radioactive Iodine I-131 Market Size, by Research Institutes, 2017-2032 (USD Million)
TABLE 189. Canada Medical Radioactive Iodine I-131 Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 190. Mexico Medical Radioactive Iodine I-131 Market Size, 2017-2032 (USD Million)
TABLE 191. Mexico Medical Radioactive Iodine I-131 Market Size, by Product, 2017-2032 (USD Million)
TABLE 192. Mexico Medical Radioactive Iodine I-131 Market Size, by Application, 2017-2032 (USD Million)
TABLE 193. Mexico Medical Radioactive Iodine I-131 Market Size, by Therapeutic, 2017-2032 (USD Million)
TABLE 194. Mexico Medical Radioactive Iodine I-131 Market Size, by End User, 2017-2032 (USD Million)
TABLE 195. Mexico Medical Radioactive Iodine I-131 Market Size, by Clinics, 2017-2032 (USD Million)
TABLE 196. Mexico Medical Radioactive Iodine I-131 Market Size, by Hospitals, 2017-2032 (USD Million)
TABLE 197. Mexico Medical Radioactive Iodine I-131 Market Size, by Research Institutes, 2017-2032 (USD Million)
TABLE 198. Mexico Medical Radioactive Iodine I-131 Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 199. Brazil Medical Radioactive Iodine I-131 Market Size, 2017-2032 (USD Million)
TABLE 200. Brazil Medical Radioactive Iodine I-131 Market Size, by Product, 2017-2032 (USD Million)
TABLE 201. Brazil Medical Radioactive Iodine I-131 Market Size, by Application, 2017-2032 (USD Million)
TABLE 202. Brazil Medical Radioactive Iodine I-131 Market Size, by Therapeutic, 2017-2032 (USD Million)
TABLE 203. Brazil Medical Radioactive Iodine I-131 Market Size, by End User, 2017-2032 (USD Million)
TABLE 204. Brazil Medical Radioactive Iodine I-131 Market Size, by Clinics, 2017-2032 (USD Million)
TABLE 205. Brazil Medical Radioactive Iodine I-131 Market Size, by Hospitals, 2017-2032 (USD Million)
TABLE 206. Brazil Medical Radioactive Iodine I-131 Market Size, by Research Institutes, 2017-2032 (USD Million)
TABLE 207. Brazil Medical Radioactive Iodine I-131 Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 208. United Kingdom Medical Radioactive Iodine I-131 Market Size, 2017-2032 (USD Million)
TABLE 209. United Kingdom Medical Radioactive Iodine I-131 Market Size, by Product, 2017-2032 (USD Million)
TABLE 210. United Kingdom Medical Radioactive Iodine I-131 Market Size, by Application, 2017-2032 (USD Million)
TABLE 211. United Kingdom Medical Radioactive Iodine I-131 Market Size, by Therapeutic, 2017-2032 (USD Million)
TABLE 212. United Kingdom Medical Radioactive Iodine I-131 Market Size, by End User, 2017-2032 (USD Million)
TABLE 213. United Kingdom Medical Radioactive Iodine I-131 Market Size, by Clinics, 2017-2032 (USD Million)
TABLE 214. United Kingdom Medical Radioactive Iodine I-131 Market Size, by Hospitals, 2017-2032 (USD Million)
TABLE 215. United Kingdom Medical Radioactive Iodine I-131 Market Size, by Research Institutes, 2017-2032 (USD Million)
TABLE 216. United Kingdom Medical Radioactive Iodine I-131 Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 217. Germany Medical Radioactive Iodine I-131 Market Size, 2017-2032 (USD Million)
TABLE 218. Germany Medical Radioactive Iodine I-131 Market Size, by Product, 2017-2032 (USD Million)
TABLE 219. Germany Medical Radioactive Iodine I-131 Market Size, by Application, 2017-2032 (USD Million)
TABLE 220. Germany Medical Radioactive Iodine I-131 Market Size, by Therapeutic, 2017-2032 (USD Million)
TABLE 221. Germany Medical Radioactive Iodine I-131 Market Size, by End User, 2017-2032 (USD Million)
TABLE 222. Germany Medical Radioactive Iodine I-131 Market Size, by Clinics, 2017-2032 (USD Million)
TABLE 223. Germany Medical Radioactive Iodine I-131 Market Size, by Hospitals, 2017-2032 (USD Million)
TABLE 224. Germany Medical Radioactive Iodine I-131 Market Size, by Research Institutes, 2017-2032 (USD Million)
TABLE 225. Germany Medical Radioactive Iodine I-131 Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 226. France Medical Radioactive Iodine I-131 Market Size, 2017-2032 (USD Million)
TABLE 227. France Medical Radioactive Iodine I-131 Market Size, by Product, 2017-2032 (USD Million)
TABLE 228. France Medical Radioactive Iodine I-131 Market Size, by Application, 2017-2032 (USD Million)
TABLE 229. France Medical Radioactive Iodine I-131 Market Size, by Therapeutic, 2017-2032 (USD Million)
TABLE 230. France Medical Radioactive Iodine I-131 Market Size, by End User, 2017-2032 (USD Million)
TABLE 231. France Medical Radioactive Iodine I-131 Market Size, by Clinics, 2017-2032 (USD Million)
TABLE 232. France Medical Radioactive Iodine I-131 Market Size, by Hospitals, 2017-2032 (USD Million)
TABLE 233. France Medical Radioactive Iodine I-131 Market Size, by Research Institutes, 2017-2032 (USD Million)
TABLE 234. France Medical Radioactive Iodine I-131 Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 235. Russia Medical Radioactive Iodine I-131 Market Size, 2017-2032 (USD Million)
TABLE 236. Russia Medical Radioactive Iodine I-131 Market Size, by Product, 2017-2032 (USD Million)
TABLE 237. Russia Medical Radioactive Iodine I-131 Market Size, by Application, 2017-2032 (USD Million)
TABLE 238. Russia Medical Radioactive Iodine I-131 Market Size, by Therapeutic, 2017-2032 (USD Million)
TABLE 239. Russia Medical Radioactive Iodine I-131 Market Size, by End User, 2017-2032 (USD Million)
TABLE 240. Russia Medical Radioactive Iodine I-131 Market Size, by Clinics, 2017-2032 (USD Million)
TABLE 241. Russia Medical Radioactive Iodine I-131 Market Size, by Hospitals, 2017-2032 (USD Million)
TABLE 242. Russia Medical Radioactive Iodine I-131 Market Size, by Research Institutes, 2017-2032 (USD Million)
TABLE 243. Russia Medical Radioactive Iodine I-131 Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 244. Italy Medical Radioactive Iodine I-131 Market Size, 2017-2032 (USD Million)
TABLE 245. Italy Medical Radioactive Iodine I-131 Market Size, by Product, 2017-2032 (USD Million)
TABLE 246. Italy Medical Radioactive Iodine I-131 Market Size, by Application, 2017-2032 (USD Million)
TABLE 247. Italy Medical Radioactive Iodine I-131 Market Size, by Therapeutic, 2017-2032 (USD Million)
TABLE 248. Italy Medical Radioactive Iodine I-131 Market Size, by End User, 2017-2032 (USD Million)
TABLE 249. Italy Medical Radioactive Iodine I-131 Market Size, by Clinics, 2017-2032 (USD Million)
TABLE 250. Italy Medical Radioactive Iodine I-131 Market Size, by Hospitals, 2017-2032 (USD Million)
TABLE 251. Italy Medical Radioactive Iodine I-131 Market Size, by Research Institutes, 2017-2032 (USD Million)
TABLE 252. Italy Medical Radioactive Iodine I-131 Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 253. Spain Medical Radioactive Iodine I-131 Market Size, 2017-2032 (USD Million)
TABLE 254. Spain Medical Radioactive Iodine I-131 Market Size, by Product, 2017-2032 (USD Million)
TABLE 255. Spain Medical Radioactive Iodine I-131 Market Size, by Application, 2017-2032 (USD Million)
TABLE 256. Spain Medical Radioactive Iodine I-131 Market Size, by Therapeutic, 2017-2032 (USD Million)
TABLE 257. Spain Medical Radioactive Iodine I-131 Market Size, by End User, 2017-2032 (USD Million)
TABLE 258. Spain Medical Radioactive Iodine I-131 Market Size, by Clinics, 2017-2032 (USD Million)
TABLE 259. Spain Medical Radioactive Iodine I-131 Market Size, by Hospitals, 2017-2032 (USD Million)
TABLE 260. Spain Medical Radioactive Iodine I-131 Market Size, by Research Institutes, 2017-2032 (USD Million)
TABLE 261. Spain Medical Radioactive Iodine I-131 Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 262. China Medical Radioactive Iodine I-131 Market Size, 2017-2032 (USD Million)
TABLE 263. China Medical Radioactive Iodine I-131 Market Size, by Product, 2017-2032 (USD Million)
TABLE 264. China Medical Radioactive Iodine I-131 Market Size, by Application, 2017-2032 (USD Million)
TABLE 265. China Medical Radioactive Iodine I-131 Market Size, by Therapeutic, 2017-2032 (USD Million)
TABLE 266. China Medical Radioactive Iodine I-131 Market Size, by End User, 2017-2032 (USD Million)
TABLE 267. China Medical Radioactive Iodine I-131 Market Size, by Clinics, 2017-2032 (USD Million)
TABLE 268. China Medical Radioactive Iodine I-131 Market Size, by Hospitals, 2017-2032 (USD Million)
TABLE 269. China Medical Radioactive Iodine I-131 Market Size, by Research Institutes, 2017-2032 (USD Million)
TABLE 270. China Medical Radioactive Iodine I-131 Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 271. India Medical Radioactive Iodine I-131 Market Size, 2017-2032 (USD Million)
TABLE 272. India Medical Radioactive Iodine I-131 Market Size, by Product, 2017-2032 (USD Million)
TABLE 273. India Medical Radioactive Iodine I-131 Market Size, by Application, 2017-2032 (USD Million)
TABLE 274. India Medical Radioactive Iodine I-131 Market Size, by Therapeutic, 2017-2032 (USD Million)
TABLE 275. India Medical Radioactive Iodine I-131 Market Size, by End User, 2017-2032 (USD Million)
TABLE 276. India Medical Radioactive Iodine I-131 Market Size, by Clinics, 2017-2032 (USD Million)
TABLE 277. India Medical Radioactive Iodine I-131 Market Size, by Hospitals, 2017-2032 (USD Million)
TABLE 278. India Medical Radioactive Iodine I-131 Market Size, by Research Institutes, 2017-2032 (USD Million)
TABLE 279. India Medical Radioactive Iodine I-131 Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 280. Japan Medical Radioactive Iodine I-131 Market Size, 2017-2032 (USD Million)
TABLE 281. Japan Medical Radioactive Iodine I-131 Market Size, by Product, 2017-2032 (USD Million)
TABLE 282. Japan Medical Radioactive Iodine I-131 Market Size, by Application, 2017-2032 (USD Million)
TABLE 283. Japan Medical Radioactive Iodine I-131 Market Size, by Therapeutic, 2017-2032 (USD Million)
TABLE 284. Japan Medical Radioactive Iodine I-131 Market Size, by End User, 2017-2032 (USD Million)
TABLE 285. Japan Medical Radioactive Iodine I-131 Market Size, by Clinics, 2017-2032 (USD Million)
TABLE 286. Japan Medical Radioactive Iodine I-131 Market Size, by Hospitals, 2017-2032 (USD Million)
TABLE 287. Japan Medical Radioactive Iodine I-131 Market Size, by Research Institutes, 2017-2032 (USD Million)
TABLE 288. Japan Medical Radioactive Iodine I-131 Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 289. Australia Medical Radioactive Iodine I-131 Market Size, 2017-2032 (USD Million)
TABLE 290. Australia Medical Radioactive Iodine I-131 Market Size, by Product, 2017-2032 (USD Million)
TABLE 291. Australia Medical Radioactive Iodine I-131 Market Size, by Application, 2017-2032 (USD Million)
TABLE 292. Australia Medical Radioactive Iodine I-131 Market Size, by Therapeutic, 2017-2032 (USD Million)
TABLE 293. Australia Medical Radioactive Iodine I-131 Market Size, by End User, 2017-2032 (USD Million)
TABLE 294. Australia Medical Radioactive Iodine I-131 Market Size, by Clinics, 2017-2032 (USD Million)
TABLE 295. Australia Medical Radioactive Iodine I-131 Market Size, by Hospitals, 2017-2032 (USD Million)
TABLE 296. Australia Medical Radioactive Iodine I-131 Market Size, by Research Institutes, 2017-2032 (USD Million)
TABLE 297. Australia Medical Radioactive Iodine I-131 Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 298. South Korea Medical Radioactive Iodine I-131 Market Size, 2017-2032 (USD Million)
TABLE 299. South Korea Medical Radioactive Iodine I-131 Market Size, by Product, 2017-2032 (USD Million)
TABLE 300. South Korea Medical Radioactive Iodine I-131 Market Size, by Application, 2017-2032 (USD Million)
TABLE 301. South Korea Medical Radioactive Iodine I-131 Market Size, by Therapeutic, 2017-2032 (USD Million)
TABLE 302. South Korea Medical Radioactive Iodine I-131 Market Size, by End User, 2017-2032 (USD Million)
TABLE 303. South Korea Medical Radioactive Iodine I-131 Market Size, by Clinics, 2017-2032 (USD Million)
TABLE 304. South Korea Medical Radioactive Iodine I-131 Market Size, by Hospitals, 2017-2032 (USD Million)
TABLE 305. South Korea Medical Radioactive Iodine I-131 Market Size, by Research Institutes, 2017-2032 (USD Million)
TABLE 306. South Korea Medical Radioactive Iodine I-131 Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 307. Global Medical Radioactive Iodine I-131 Market Share, by Key Player, 2025
TABLE 308. Global Medical Radioactive Iodine I-131 Market, Key Experts

Companies Mentioned

  • Advanced Biomedicals
  • Bayer AG
  • Biodex Medical Systems
  • Bracco Imaging S.p.A.
  • CIS Bio International
  • Curium Pharma
  • Fujifilm Holdings Corporation
  • GE Healthcare
  • IBA Molecular
  • Isotope Products Laboratories
  • ITM Isotope Technologies Munich
  • Jubilant DraxImage Inc.
  • Lantheus Medical Imaging
  • Mallinckrodt Pharmaceuticals
  • Nordion Canada
  • Nordion Inc.
  • Nordion Ltd.
  • PerkinElmer, Inc.
  • Radiopharm Theranostics
  • SHINE Medical Technologies
  • Siemens Healthineers
  • Sumitomo Heavy Industries, Ltd.

Related Topics

Related Reports

Iodine-131 Isotope Market - Global Forecast 2026-2032 - Product Image

Iodine-131 Isotope Market - Global Forecast 2026-2032

  • Report
  • 186 Pages
  • Global
From
Iodine Radioisotope Market - Global Forecast 2026-2032 - Product Image

Iodine Radioisotope Market - Global Forecast 2026-2032

  • Report
  • 182 Pages
  • Global
From
Iodine Market Report by Source, Form, Application, and Region 2026-2034 - Product Image

Iodine Market Report by Source, Form, Application, and Region 2026-2034

  • Report
  • 146 Pages
  • Global
From
Graves Disease Market Outlook 2026-2034: Market Share, and Growth Analysis by Treatment (Anti-Thyroid Medication, Radioactive Iodine Therapy, Surgery (Thyroidectomy), Targeted Immunotherapies & Biologics, Ultrasound-Guided Thermal Ablation), Patient Age Group, End-User - Product Image

Graves Disease Market Outlook 2026-2034: Market Share, and Growth Analysis by Treatment (Anti-Thyroid Medication, Radioactive Iodine Therapy, Surgery (Thyroidectomy), Targeted Immunotherapies & Biologics, Ultrasound-Guided Thermal Ablation), Patient Age Group, End-User

  • Report
  • 160 Pages
  • Global
From
Iodine Market Report 2026 - Product Image

Iodine Market Report 2026

  • Report
  • 250 Pages
  • Global
From
Copyright © 2002-2026 Research and Markets. All Rights Reserved.